RSV Vaccine Approved by Health Canada for Patients Over 60
Respiratory syncytial virus (RSV) is a common and potentially serious respiratory infection that affects people of all ages, especially infants and older adults. While infants have long been the focus of RSV prevention efforts, older adults have often been overlooked. However, a new RSV vaccine called Arexvy, developed by GlaxoSmithKline (GSK), is changing the landscape … Read more